委员会意见第682号:微阵列与下一代测序技术:先进遗传诊断工具在妇产科中的应用
本文为妇产科委员会意见,阐述染色体微阵列和全外显子测序两种产前遗传诊断技术。推荐对超声发现胎儿一个或多个主要结构异常且接受侵入性产前诊断者行产前染色体微阵列分析;不推荐在临床试验之外常规使用全基因组或全外显子测序进行产前诊断。
要点
- 产前染色体微阵列分析推荐用于超声发现胎儿一个或多个主要结构异常且接受侵入性产前诊断的患者。
- 全外显子测序检测编码区(外显子),外显子通常比内含子具有更大的临床相关性和适用性。
- 不推荐在临床试验之外常规使用全基因组或全外显子测序进行产前诊断。
核心结论
- 产前染色体微阵列分析推荐用于超声发现胎儿一个或多个主要结构异常且接受侵入性产前诊断的患者。
- 不推荐在临床试验之外常规使用全基因组或全外显子测序进行产前诊断。
研究设计与样本
- 本文为妇产科委员会意见,阐述染色体微阵列和全外显子测序两种产前遗传诊断技术。
主要发现
- 染色体微阵列分析可检测染色体非整倍体、染色体结构的大改变以及传统方法无法检测的亚显微异常。
- 全基因组测序分析整个基因组,包括非编码区(内含子)和编码区(外显子)。
- 由于内含子通常临床相关性小,焦点转向检测编码区(外显子)的全外显子测序,外显子通常具有更大的临床相关性和适用性。
关键数值与推荐
- 产前染色体微阵列分析推荐用于超声发现胎儿一个或多个主要结构异常且接受侵入性产前诊断的患者。
- 不推荐在临床试验之外常规使用全基因组或全外显子测序进行产前诊断。
临床怎么用
- 对超声发现胎儿一个或多个主要结构异常且接受侵入性产前诊断的患者,推荐行产前染色体微阵列分析。
- 全基因组或全外显子测序用于产前诊断仅应在临床试验背景下进行。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genetic technology has advanced dramatically in the past few decades, and its applications and use in caring for and counseling pregnant women has been transformational in the realm of prenatal diagnosis. Two of the newer genetic technologies in the prenatal setting are chromosomal microarray and whole-exome sequencing. Chromosomal microarray analysis is a method of measuring gains and losses of DNA throughout the human genome. It can identify chromosomal aneuploidy and other large changes in the structure of chromosomes as well as submicroscopic abnormalities that are too small to be detected by traditional modalities. Prenatal chromosomal microarray analysis is recommended for a patient with a fetus with one or more major structural abnormalities identified on ultrasonographic examination and who is undergoing invasive prenatal diagnosis. Whole-genome sequencing analyzes the entire genome, including noncoding regions (introns) and coding regions (exons). However, because the introns are typically of little clinical relevance, there has been a focus instead on whole-exome sequencing, which examines the coding regions (exons) of the genome. The exons generally have greater clinical relevance and applicability to patient care. However, the routine use of whole-genome or whole-exome sequencing for prenatal diagnosis is not recommended outside of the context of clinical trials.
引用
- Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obstet Gynecol. 2016. PMID: 27875474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。